The availability of relatively simple measures to identify apparently healthy people who are sufficiently insulin resistant to be at increased risk of developing type 2 diabetes, cardiovascular disease, and the numerous other clinical syndromes that occur with increased frequency in insulin-resistant persons would be of significant clinical benefit [6-8]. The gene discussed is INS; the disease is type 2 diabetes mellitus.